Navigation Links
Takeda Responds to Announcement about Suspension of Rosiglitazone Marketing Authorization in Europe and Restrictions in the U.S.
Date:9/23/2010

p>ACTOS is not for patients with type 1 "juvenile" diabetes or diabetic ketoacidosis.

ACTOS may cause low blood sugar when taken in combination with insulin or other oral antidiabetic drugs. Lightheadedness, shakiness, dizziness, or hunger may mean that a patient's blood sugar is too low. Patients should talk to their doctor if low blood sugar is a problem for them.

Some people taking ACTOS may experience flulike symptoms, mild-to-moderate swelling of legs and ankles, anemia, and weight gain.

If a patient is of childbearing age, they should talk to their doctor before taking ACTOS, as it could increase their chance of becoming pregnant. Patients should talk to their doctor if they are pregnant, planning to become pregnant, breastfeeding, or planning to breastfeed.

A patient should not take ACTOS if they have active liver disease. A doctor should perform a blood test to check for liver problems before a patient starts ACTOS and periodically thereafter. Patients should talk to their doctor immediately if they experience nausea, vomiting, stomach pain, unusual tiredness, loss of appetite, dark urine, or yellowing of the skin or eyes.

Patients with diabetes should have regular eye exams. If a patient experiences vision problems, they should consult with their doctor immediately. Some patients have experienced visual changes while taking ACTOS. Some people, particularly women, are at higher risk of having bone fractures while taking ACTOS. Other side effects may include cold-like symptoms, headache, sinus infection, muscle pain, tooth disorder, and sore throat.

Individuals are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Takeda encourages those with questions to speak with their health care provider. For the U.S. Complete Prescribing Information, including warnings about heart failure and M
'/>"/>

SOURCE Takeda Pharmaceutical North America, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Arthritis Foundation and Takeda Launch First-Ever National Gout Public Service Announcement (PSA) Campaign, Urging People Living With Gout to Keep Enjoying Lifes Simple Pleasures
2. Orexigen® Therapeutics and Takeda Enter Into Partnership to Commercialize Contrave® in North America
3. Takeda Responds to FDA Advisory Committee Recommendation
4. Takeda Provides Update on Patent Litigation for ACTOS(R) (pioglitazone HCl) and ACTOplus met(R) (pioglitazone HCl and metformin HCl) in the U.S.
5. CellCentric Licenses Novel Epigenetic Discovery Programme to Takeda
6. Amylin and Takeda Announce Decision to Advance Development of Pramlintide/Metreleptin Combination Treatment for Obesity
7. Takeda Announces Initiation of Trial to Study the Concomitant Use of Dexlansoprazole and Other Proton Pump Inhibitors with Plavix(R) (clopidogrel bisulfate)
8. Emerging Agents from Theravance/Astellas, Johnson & Johnson/Basilea and Forest/Astrazeneca/Takeda Will Drive Modest Growth in the MRSA Drug Market Through 2018
9. Takeda San Francisco, Inc. Appoints Michael Buckley, Ph.D. Vice President of Process Sciences
10. Takeda to Establish Four Sales and Marketing Subsidiaries to Expand Its Operations in Mexico, Turkey and Five Other Countries in Europe
11. Takeda Receives FDA Complete Response Letter for the Investigational Fixed-Dose Combination of alogliptin and ACTOS(R) (pioglitazone HCl) for the Treatment of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... The Coalition of State Rheumatology Organizations ... professional rheumatology societies, today released the findings of ... of biosimilars and the potential impact of these ... are medicines that are highly similar, but not ... from generic medications in that it is impossible ...
(Date:7/1/2015)... July 1, 2015 ContraVir Pharmaceuticals, Inc. (NASDAQ: ... development and commercialization of targeted antiviral therapies, announced today ... Healthcare Conference taking place in New York, ... Parker Meridien Hotel. James Sapirstein ... the Company,s business during his live presentation and will ...
(Date:7/1/2015)... INDIANAPOLIS , July 1, 2015 Eli Lilly ... results for the second quarter of 2015 on Thursday, July ... that day with the investment community and media to further ... will begin at 9 a.m. EDT. Investors, media and the ... call through a link that will be posted on Lilly,s ...
Breaking Medicine Technology:Survey Of Rheumatologists Nationwide Regarding Biosimilars Highlights Need For More Robust FDA Standards 2ContraVir to Present at Cantor Fitzgerald Inaugural Healthcare Conference 2Lilly Confirms Date and Conference Call for Second-Quarter 2015 Financial Results Announcement 2
... YINCHUAN, China , July ... Nie Wentao,s nutrition intervention technology for type 1,diabetes mellitus. ... technology for diabetes treatment, so it aroused widespread,concern in ... the study of nutrition,interventions on diabetes mellitus for a ...
... July 14 Osseon Therapeutics, Inc., a biomedical ... received a notice of allowance for its spinal vertebral compression ... has thirteen additional patent applications pending in the United ... and devices. The lead inventor for this inaugural patent is ...
Cached Medicine Technology:Dr. Nie Wentao's New Method of Diabetic Nutrition Interventions 2Dr. Nie Wentao's New Method of Diabetic Nutrition Interventions 3Dr. Nie Wentao's New Method of Diabetic Nutrition Interventions 4Dr. Nie Wentao's New Method of Diabetic Nutrition Interventions 5Osseon Receives Patent Allowance for Novel Spinal VCF Treatment Devices 2
(Date:7/2/2015)... ... July 02, 2015 , ... Cs &A, the leader ... announced the release and publication of their newest offering to complement the existing ... Newsletter. , Designed in support of coverage for the full spectrum of ...
(Date:7/2/2015)... ... July 02, 2015 , ... Maddock Douglas is ... and business models. To help manage the increasing demand for innovation as a ... as SVP of Strategic Engagements. , Benkendorf is a seasoned management executive with ...
(Date:7/1/2015)... ... 01, 2015 , ... In the United States, summer has always been the ... Saudi Arabia and Dubai, the summer temperatures are so hot, that July vacationers often ... Sam Saleh of ORA Dentistry Spa notes that a trip to the United States, ...
(Date:7/1/2015)... ... 01, 2015 , ... Dr. Jian-Dong Li, a professor and ... Georgia Research Alliance Eminent Scholar in Inflammation and Immunity, has received a five-year, ... The grant from the National Institute on Deafness and Other Communication Disorders of ...
(Date:7/1/2015)... ... July 01, 2015 , ... The federal court ... http://www.injurybeacon.com/levaquin/lawsuit/ ) has granted the Defendants’ Motion for Summary Judgment. According to an ... June 26th, the Court rejected the Plaintiff’s assertion that one manufacturer can ...
Breaking Medicine News(10 mins):Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 2Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 3Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 4Health News:Business Builder Mark Benkendorf Joins Innovation Firm Maddock Douglas 2Health News:Dr. Sam Saleh Invites Vacationing International Patients to Get a Same-Day Hollywood Smile During the July Travel Season 2Health News:Institute for Biomedical Sciences Researcher Gets $1.6 Million to Develop Anti-Inflammatory Drug 2Health News:Levaquin Lawsuit Attorneys at Bernstein Liebhard LLP Comment on Decision to Grant Summary Judgment in Generic Drug Case 2Health News:Levaquin Lawsuit Attorneys at Bernstein Liebhard LLP Comment on Decision to Grant Summary Judgment in Generic Drug Case 3
... By Jenifer Goodwin HealthDay Reporter , THURSDAY, ... Ellie, was diagnosed with a severe peanut allergy, the New ... and never leaves home without it. The device contains ... even life-threatening allergic reactions. But it,s not only Able ...
... , THURSDAY, Feb. 9 (HealthDay News) -- The number ... to engage in regular exercise has increased steadily over ... health officials. The U.S. Centers for Disease Control ... more Americans lower their risk for chronic illnesses, reduce ...
... Feb. 9, 2012 Wake Forest Baptist Medical Center ... into tumors and heating them with a quick, 30-second laser ... effort involving kidney tumors was published in 2009, but now ... tumors, specifically the tumor initiating cancer stem cells. These stem ...
... and under-studied subset of diseases affecting the lymphatic system ... disease is the focus of a special issue of ... published by Mary Ann Liebert, Inc. . The ... Guest Editor, and Journal Associate Editor Francine ...
... certain cancer cells may exhibit greater flexibility than normal ... tumor growth. Now computer simulations developed by Boston University ... the University of Texas at Austin appear to support ... cells that they,ve created indicates that the softening of ...
... 9 (HealthDay News) -- ,The longer Hispanic women live in the ... birth, a new study says. Researchers analyzed data from 2,141 ... the U.S. National Health and Nutrition Examination Survey 1999-2006. The ... for women who had lived in the United States for less ...
Cached Medicine News:Health News:More People Need Training in Lifesaving Epinephrine Use, Advocates Say 2Health News:More People Need Training in Lifesaving Epinephrine Use, Advocates Say 3Health News:More U.S. Doctors Are Urging Patients to Exercise: CDC 2Health News:Nanotube therapy takes aim at breast cancer stem cells 2Health News:Boston University research suggests new pathways for cancer progression 2
HST, multi frequency Side Fire "T intraoperative transducer. A wide field of view is this transducers benefit....
Super High Density, 120 field of view, angled handle, multi-frequency, convex endovaginal transducer....
Provides tremendous image quality along with a 180 degree field of view....
Prostate biopsy transducer....
Medicine Products: